Foley & Small has handled a variety of defective medical implant claims. We have helped those injured by such defective implants and their families during a difficult period of medical treatment and recovery, coordinating insurance and other coverage benefits, dealing with loss of pay claims, issues a permanent impairment and overall recovery.
Foley & Small has and is handling a variety of cases involving the recall of defective medical implants and devices. This includes cases in a number of different MDL proceedings throughout the United States involving defects with knee implants and with hip implants. Foley & Small is also representing women from Indiana and Michigan who have suffered injuries as a result of having had implanted vaginal mesh products which have proven defective and dangerous. A number of different manufacturers are involved, including Ethicon, Bard, Boston Scientific, American Medical, Coloplast and others. These cases have been consolidated in MDL proceedings in the federal district court located in West Virginia.
Before a medical implant, such as an artificial hip or knee or cardiac pacemaker, can be sold in the United States, the manufacturer must put the device through testing and trials. The manufacturer then must submit the implant to the Food and Drug Administration (FDA) for approval before the device can be distributed in the United States. At times, implant manufacturers push the FDA to approve a medical implant before of the safety and efficacy of the implant has been adequately and fully tested. They do this for a variety of reasons, some good – to make the device available to patients who need it, and some bad – to get the device to market as soon as possible to start making a profit on its sale. Due to its limited resources, the FDA is unable to carefully test and screen all such devices or surgical tools. Sometimes, the FDA approves a new device or implant on the basis of its “substantial similarity” to an already existing device. Unfortunately, this can and has led to instances where a device has been approved and it is later discovered that the device is defective as failures occur after the device or implant has been placed in patients.
Once the device has been placed on the market, the FDA continues to monitor it through post-marketing reports sent in by the manufacturer and through the MedWatch program, an FDA program that allows consumers and health care professionals to report serious side effects or defects, quality control issues and medical errors associated with the device.
Each year medical device makers offer for sale and use hundreds of medical devices, including joint replacement implants, such as knees, hips and other joints; cosmetic implants, such as breast implants; and offer surgical instruments. Sometimes, unanticipated side effects or defects are discovered after the implant or device is approved for use. If the problem is serious enough, the FDA may issue a warning to the public. If the problem or defect is sufficiently dangerous, the FDA may decide that the risks of the device outweigh its benefits and issue a recall. When this occurs the patient should receive written notification of the recall and information on what to do in response to the defective product.
The FDA is supposed to be responsible for testing and approving each and every medical device for safety and efficacy. However, the truth is that the FDA is unable to carefully test and screen all such devices or surgical tools. In recent years, the approval process for medical devices has been accelerated as multi-national manufacturers motivated by the desire for profit have pushed harder and harder for fast device approval and less rigorous testing. Oftentimes, the FDA simply approves a new device, prosthesis, or implant on the basis of its “substantial similarity” to an already existing device.
A wide variety of medical implants have either been recalled or challenged in litigation as being defective.
In September 2010, DePuy Orthopaedics, Inc. issued a recall of its ASR Hip Replacement Systems. This DePuy recall followed reports of a higher than acceptable failure rate often requiring another hip replacement surgery within 5 years. It is estimated that the DePuy ASR hip systems have been implanted in 93,000 patients. This hip recall only affects patients who had hip surgery after July 2003. Thousands of patients have already reported experiencing hip implant problems including: serious or ongoing pain, swelling and loosening or dislocation of the hip implant.
Davol Inc., the manufacturer of the Bard Composix Kugel Mesh Hernia Repair Patch, issued the first hernia patch recall in December 2005 after problems were detected with the “memory-recoil ring” which surrounds the device. Further related hernia patch products were recalled in 2007. The ring allows the hernia patch to be folded in half during surgery and then springs back into place when the device is placed at the spot of a hernia. In many cases, however, the memory recoil ring broke after it was implanted, which can lead to serious injury, including bowel perforation, bowel obstruction and chronic enteric fistulas (abnormal connections between two sections of the intestines).
These are just two examples of defective medical implant recalls.
-Douglas D. Small
-Edmond W. Foley
If you, a friend or family member has suffered injury due to a defective medical implant email us from our Contact page. You can also call us at 800-276-2525.
Foley & Small has handled numerous defective medical implant cases helping our clients and their families deal with the effects of such defective products.
Retail store slip and fall claim resulting in brain injury.
Represented estate of employee injured as a result of an at-work explosion caused by third party contractor.
Represented woman injured due to defective product resulting in injuries involving significant complications and multiple follow up procedures.
Represented estate of construction worker injured who suffered fatal injuries during the course of assisting and the unloading of construction materials from a trailer.
Represented estate of man electrocuted while working on farm property. Settlement with certain defendants and trial with one defendant.
Represented estate of middle age woman who suffered fatal injuries during the course of a car semi-tractor collision.
Represented estate of man who died from injuries due to collision with a semi-tractor trailer.
Represented family members suffering injury after being struck by a delivery vehicle which failed to stop for a stop sign.
Represented delivery driver of RV units injured in crash with vehicle on interstate highway resulting in severe lower extremity injuries. Settlements with two defendants and verdict against a third defendant.
Represented client rearended by truck resulting in concussive and hand injuries.
Represented client involved in an intersectional accident resulting in chest and upper extremity injuries.
Represented woman struck by a vehicle involved in a high speed auto chase.
Represented high school student injured in highway intersection accident suffering vertebral fractures.
Represented elderly handicapped gentlemen who fell on asphalt debris in apartment complex parking lot.
Represented woman injured at county road intersection collision suffering complex hand injuries.
Lead counsel in Indiana working to secure a settlement of $125,000,000.00 against the New England Compounding Center and its officers, directors and employees arising from fungus contaminated epidural injections distributed throughout the United States, including Indiana and Michigan.
Represented worker injured at work site due to injuries caused by third party contractors (not employer).
Foley & Small handles and tries cases across Indiana and Michigan. This includes working in the following counties, county seats and cities: